Back to results
US 2024/0254206 A1Published application
Human Immunodeficiency Virus Neutralizing Antibodies And Methods Of Use Thereof
AssigneesThe Rockefeller University, California Institute of Technology
InventorsJohannes Scheid, Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin
Life of this patent
Estimating the term…
Abstract
The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.
Claims23
A non-naturally occurring anti-HIV gp120 antibody or antigen binding fragment thereof, comprising a heavy chain variable region (VH) comprising the amino acid sequence of SEQ ID NO:
- 892, and a light chain variable region (VL) comprising the amino acid sequence of SEQ ID NO:
- 906.
Dependencies are inferred from the claim text.